The brain of the gunman in Monday’s deadly shootings at the Manhattan building that houses the NFL’s offices will be evaluated for the degenerative disorder from which he claimed to be suffering, ...

While Eli Lilly’s diabetes blockbuster was non-inferior to its older incretin therapy Trulicity in a highly anticipated Phase III cardiovascular outcomes trial, analysts had hoped for statistical ...

A variety of GLP-1 drugs that were developed to treat Type 2 diabetes, including Novo Nordisk’s Ozempic, have secured label ...

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type ...

There are many reasons to avoid ultraprocessed foods, including a link with heart disease, diabetes and obesity, but an ...

A caseworker assigned to monitor Illinois foster child Mackenzi Felmlee — who later died in May 2024 — had a troubled past.

On a scorching summer afternoon in July 1970, something was wrong at the Hilltop Apartments in Odessa. A resident named ...

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

The man accused of fatally shooting four people in a Manhattan office building before turning the gun on himself on Monday, ...

Didarul Islam, a 36-year-old New York Police Department officer, was among four people killed in Midtown Manhattan ...

Though GLP-1 drugs drive major weight loss, researchers warn they may fall short in improving heart and lung fitness. Protecting muscle mass may be key to unlocking their full health potential. Widely ...

A comprehensive US analysis showed that progress in multiple myeloma survival has not been shared equally, with significant disparities persisting despite improved therapies.